Literature DB >> 31625175

Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker.

Tian Li1,2, Xiangzhou Sun3, Liheng Chen4.   

Abstract

Circular RNAs (circRNAs) are important regulators in cancer growth and progression. Exosomes carry various molecules including RNA, protein, and lipid from one cell to another cell. But the role of circRNAs from the exosomes from prostate cancer patients are not elucidated. In this study, circ_0044516 was found upregulated in prostate cancer and the roles and molecular mechanism of Hsa_circ_0044516 (circ_0044516) was investigated. Firstly, the exosomes of prostate cancer patients were collected for human circRNAs microarray to screen the circRNA expression profile. There were 35 significantly expressed circRNAs with more than fivefolds from microarray analysis. Circ_0044516 was verified to be significantly upregulated in the exosomes from prostate cancer patients and the cell lines. Further investigation demonstrated that circ_0044516 downregulation inhibited the proliferation and metastasis of prostate cancer cells. By bioinformatics and luciferase reporter assays, circ_0044516 was verified to downregulate miR-29a-3p expression and negatively related to miR-29a-3p expression levels in prostate cancer. In a summary, the study indicated that circ_0044516 played an important role in prostate cancer cell survival and metastasis, which suggested that an oncogenic role of circ_0044516 in prostate cancer.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  cell proliferation; hsa_circ_0044516; metastasis; miR-29a-3p; prostate cancer

Mesh:

Substances:

Year:  2019        PMID: 31625175     DOI: 10.1002/jcb.28239

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  52 in total

1.  Exosomal circKDM4A Induces CUL4B to Promote Prostate Cancer Cell Malignancy in a miR-338-3p-Dependent Manner.

Authors:  Guangyi Huang; Zeping Jiang; Wuan Zhu; Zhiyue Wu
Journal:  Biochem Genet       Date:  2022-08-05       Impact factor: 2.220

2.  Exosomal circ-BRWD1 contributes to osteoarthritis development through the modulation of miR-1277/TRAF6 axis.

Authors:  Zhenye Guo; Huan Wang; Feng Zhao; Min Liu; Feida Wang; Mingming Kang; Weifu He; Zhi Lv
Journal:  Arthritis Res Ther       Date:  2021-06-03       Impact factor: 5.156

Review 3.  Extracellular vesicles in prostate cancer: a narrative review.

Authors:  Koji Hatano; Kazutoshi Fujita
Journal:  Transl Androl Urol       Date:  2021-04

4.  Exosomal circRNAs: a new communication method in cancer.

Authors:  Jia-Lin Xu; Wen-Xiu Xu; Jin-Hai Tang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 5.  Functions of circular RNAs in bladder, prostate and renal cell cancer (Review).

Authors:  Longfei Yang; Xiaofeng Zou; Junrong Zou; Guoxi Zhang
Journal:  Mol Med Rep       Date:  2021-03-02       Impact factor: 2.952

6.  Circ_0003340 downregulation mitigates esophageal squamous cell carcinoma progression by targeting miR-940/PRKAA1 axis.

Authors:  Xingzhuo Guan; Xiaohui Guan; Yuanshi Wang; Tingzhu Lan; Tongshuang Cheng; Yan Cui; Hongjun Xu
Journal:  Thorac Cancer       Date:  2022-03-17       Impact factor: 3.223

7.  Circ_0061140 stimulates the malignant development of prostate cancer by targeting miR-1193.

Authors:  Kai Wang; Yi Fan; Ji Sun; Liwei Zhao; Yufu Yu; Gonghui Li
Journal:  Transl Androl Urol       Date:  2021-05

8.  Exosome to Promote Cancer Progression via Its Bioactive Cargoes.

Authors:  Austin McMasters; Kelly M McMasters; Hongying Hao
Journal:  Arch Cancer Biol Ther       Date:  2021-06

9.  Circ_0044516 Regulates miR-136/MAT2A Pathway to Facilitate Lung Cancer Development.

Authors:  Yue-Wei Chen; Qiu-Rong Du; Yu-Juan He; Wen-Shu Chen; Wen-Yang Jiang; Qi Gui; Cheng-Cheng Xu; Wei Wang; Hong-Yun Cheng
Journal:  J Immunol Res       Date:  2021-06-24       Impact factor: 4.818

10.  CircLRP6 contributes to prostate cancer growth and metastasis by binding to miR-330-5p to up-regulate NRBP1.

Authors:  Linghui Qin; Xiaosong Sun; Fei Zhou; Cheng Liu
Journal:  World J Surg Oncol       Date:  2021-06-22       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.